{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amlodipine+5+mg+capsule", "query": { "intervention": "Amlodipine 5 mg capsule" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Amlodipine+5+mg+capsule&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T06:33:59.966Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00439738", "title": "Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "HCTZ + Amlodipine", "type": "DRUG" }, { "name": "Valsartan/HCTZ", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 412, "start_date": "2006-12", "completion_date": null, "has_results": true, "last_update_posted_date": "2017-05-16", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 5, "location_summary": "Muscle Shoals, Alabama • Westlake Village, California • Oklahoma City, Oklahoma + 2 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Westlake Village", "state": "California" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Euless", "state": "Texas" }, { "city": "Port Orchard", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00439738" }, { "nct_id": "NCT00931710", "title": "Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Stage 2 Systolic Hypertension" ], "interventions": [ { "name": "valsartan, amlodipine, HCTZ", "type": "DRUG" }, { "name": "Losartan, HCTZ followed by valsartan, amlodipine, HCTZ", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 488, "start_date": "2009-07", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2011-03-07", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00931710" }, { "nct_id": "NCT01368536", "title": "Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension", "Stage 2 Hypertension", "Diabetes" ], "interventions": [ { "name": "Valturna", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "Chlorthalidone", "type": "DRUG" }, { "name": "Placebo of Valturna Tablet", "type": "DRUG" }, { "name": "Placebo Capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 975, "start_date": "2011-05", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2013-03-21", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 95, "location_summary": "Athens, Alabama • Florence, Alabama • Huntsville, Alabama + 78 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01368536" }, { "nct_id": "NCT00368277", "title": "A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Aliskiren", "type": "DRUG" }, { "name": "Ramipril", "type": "DRUG" }, { "name": "Hydrochlorothiazide", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 901, "start_date": "2006-09", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2011-03-25", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00368277" }, { "nct_id": "NCT00170950", "title": "Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Benazepril/amlodipine 20/5 mg - Dose Level 1 from Day 1 to Month 1", "type": "DRUG" }, { "name": "Benazepril/amlodipine 40/5 mg - Dose Level 2 from Month 1 to Month 2", "type": "DRUG" }, { "name": "Benazepril/amlodipine 40/10 mg - Dose Level 3 from Month 2 to Month 3 and thereafter", "type": "DRUG" }, { "name": "Benazepril/hydrochlorothiazide 20/12.5 mg - Dose Level 1 from Day 1 to Month 1", "type": "DRUG" }, { "name": "Benazepril/hydrochlorothiazide 40/12.5 mg - Dose Level 2 from Month 1 to Month 2", "type": "DRUG" }, { "name": "Benazepril/hydrochlorothiazide 40/25 mg - Dose Level 3 from Month 2 to Month 3 and thereafter", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 11506, "start_date": "2003-10", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2023-10-24", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00170950" }, { "nct_id": "NCT00417170", "title": "Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "High Blood Pressure", "Metabolic Syndrome", "Insulin Resistance", "Endothelial Dysfunction" ], "interventions": [ { "name": "Aliskiren", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "Placebo Aliskiren", "type": "DRUG" }, { "name": "Placebo Amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 48, "start_date": "2007-10", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2011-09-26", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 1, "location_summary": "Santa Monica, California", "locations": [ { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00417170" }, { "nct_id": "NCT00667719", "title": "A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Essential Hypertension" ], "interventions": [ { "name": "Aliskiren", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "Hydrochlorothiazide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 564, "start_date": "2008-06-05", "completion_date": "2009-10-05", "has_results": true, "last_update_posted_date": "2021-06-07", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00667719" }, { "nct_id": "NCT00739973", "title": "Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Aliskiren 150 mg tablet", "type": "DRUG" }, { "name": "Aliskiren 300 mg tablet", "type": "DRUG" }, { "name": "Amlodipine 5 mg capsule", "type": "DRUG" }, { "name": "Amlodipine 10 mg capsule", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 150/5 mg tablet", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 150/10 mg tablet", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 300/5 mg tablet", "type": "DRUG" }, { "name": "Aliskiren/amlodipine 300/10 mg tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2694, "start_date": "2008-09", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2011-06-06", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00739973" }, { "nct_id": "NCT00765674", "title": "Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Aliskiren", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" }, { "name": "Hydrochlorothiazide (HCTZ)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1191, "start_date": "2008-09", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2011-05-09", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00765674" }, { "nct_id": "NCT00942994", "title": "Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Aliskiren/Amlodipine", "type": "DRUG" }, { "name": "Aliskiren/Amlodipine and Hydrochlorothiazide (HCTZ)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 412, "start_date": "2009-06", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-06-08", "last_synced_at": "2026-09-26T06:33:59.966Z", "location_count": 5, "location_summary": "Little Rock, Arkansas • South Miami, Florida • Mattapan, Massachusetts + 2 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "South Miami", "state": "Florida" }, { "city": "Mattapan", "state": "Massachusetts" }, { "city": "Manassas", "state": "Virginia" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00942994" } ] }